A detailed history of Nebula Research & Development LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 5,468 shares of ZTS stock, worth $800,624. This represents 0.07% of its overall portfolio holdings.

Number of Shares
5,468
Previous 12,038 54.58%
Holding current value
$800,624
Previous $1.98 Billion 56.98%
% of portfolio
0.07%
Previous 0.18%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

SELL
$144.41 - $170.3 $948,773 - $1.12 Million
-6,570 Reduced 54.58%
5,468 $853 Million
Q1 2025

May 15, 2025

BUY
$156.48 - $175.67 $1.88 Million - $2.11 Million
12,038 New
12,038 $1.98 Billion
Q1 2024

May 15, 2024

BUY
$165.67 - $199.94 $435,049 - $525,042
2,626 New
2,626 $444 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $68.5B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Nebula Research & Development LLC Portfolio

Follow Nebula Research & Development LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nebula Research & Development LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nebula Research & Development LLC with notifications on news.